Canadian researchers say Pfizer vaccine's second dose can be delayed as first is highly effective
Published
The second dose of Pfizer Inc's COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.
Full Article